Ciprofibrate
Top View
- Ciprofibrate 100Mg Tablets
- Antidiabetic Action of Bezafibrate in a Large Observational Database
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- (12) United States Patent (10) Patent No.: US 6,696,084 B2 Pace Et Al
- A Review on Anti-Cholesterol Drugs and Their Mechanisms
- Lipid Management in Patients with Endocrine Disorders: an Endocrine
- 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
- Prevention of Murine Atherosclerosis with Bempedoic Acid
- Technology Road Mapping for Innovation Pathways of Fibrates: a Cross-Database Patent Review
- Disease Agonists As Therapy for Autoimmune Α Peroxisome
- PPAR-Mediated Toxicology and Applied Pharmacology
- Accessibility Improving Information Using Online Patient Drug Reviews
- New Product Highlights
- Coadministration of Multidrug Therapy to Achieve Lipid Goals JAOA • Supplement 7 • Vol 104 • No 9 • September 2004 • S17 Drug Class Mechanism of Action
- WO 2018/148417 Al 16 August 2018 (16.08.2018) W!P O PCT
- Fenofibrate: a Novel Formulation (Triglide™) in the Treatment of Lipid Disorders: a Review
- Proposed OPPTS Science Policy: PPAR-Alpha Mediated
- ESC/EAS Guidelines for the Management of Dyslipidemias